EUVIMEDEUVIMED entdecken
Multizentrische Studie

Liver fibrosis marker is a potential predictor of the development of Fontan-associated liver diseases

Sakura Horie iD, Fumiaki Shikata, Norihiko Oka, Toru Okamura, Yoshikiyo Matsunaga, Kenta Matsui, Tsutomu Hataoka, Tadashi Kitamura iD, Masaomi Fukuzumi, Ryoichi Kondo, Yoichiro Hirata, Kagami Miyaji

European Journal of Cardio-Thoracic Surgery · 28.03.2025 · 67 (4)

DOI: 10.1093/ejcts/ezaf100 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 25.03.2025. Verfasst von Sakura Horie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Kitasato University School of Medicine, Kanagawa, Japan. Hauptthemen laut MEDLINE: Fontan Procedure, Liver Cirrhosis, Postoperative Complications, Liver Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES To evaluate how well liver fibrosis markers (fibrosis-4 index, aspartate aminotransferase to platelet ratio index, and model for end-stage liver disease excluding international normalized ratio score) can predict early detection of Fontan-associated liver disease and to identify risk factors for Fontan-associated liver disease development. METHODS This retrospective multicentre study included patients who underwent the Fontan procedure between 2004 and 2020 with at least 3 years of follow-up. Blood tests and imaging were conducted to diagnose Fontan-associated liver disease. The predictive value of these markers was assessed using receiver operating characteristic curve analysis. Risk factors for Fontan-associated liver disease development were identified using Fine–Gray subdistribution hazard analysis. RESULTS This study included 137 patients. The fibrosis-4 index, measured at 2 years post-Fontan, was a strong predictor for Fontan-associated liver disease development 10 years later (area under the curve: 0.81, optimal cutoff value: 0.17, 83.1% sensitivity, and 73.0% specificity). Fine–Gray subdistribution hazard analysis shows that a fibrosis-4 index level was a key risk factor for Fontan-associated liver disease. Patients with a fibrosis-4 index >0.17 after 2 years had a higher incidence of Fontan-associated liver disease after 10 years (45.6%) than patients with fibrosis-4 index ≤0.17 (3.9%, P = 0.002). These patients also had higher pulmonary artery pressure 5 years later. CONCLUSIONS The fibrosis-4 may be a useful marker for early detection of Fontan-associated liver disease, which, in this study, was identified as a risk factor for the disease’s development. CLINICAL REGISTRATION NUMBER Kitasato University, No. B23-130; 7 February 2024.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fontan ProcedureLiver CirrhosisPostoperative ComplicationsLiver DiseasesHumansRetrospective StudiesMaleFemaleBiomarkersChildRisk FactorsChild, PreschoolAdolescentAspartate AminotransferasesAdultHeart Defects, CongenitalPredictive Value of TestsROC Curve

Stichwörter der Autor:innen

Fontan failureFontan-associated liver diseaseLiver fibrosis marker

Substanzen

BiomarkersAspartate Aminotransferases

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Kitasato University School of Medicine, Kanagawa, Japan.
  • Department of Cardiac Surgery, The University of Tokyo Hospital, Tokyo, Japan.
  • Pediatric and Congenital Cardiovascular Surgery, Jichi Children's Medical Center, Tochigi, Japan.
  • Department of Cardiovascular Surgery, Gunma Children's Medical Center, Gunma, Japan.
  • Department of Pediatrics, Kitasato University School of Medicine, Kanagawa, Japan.

ORCID-Profile: Sakura Horie, Tadashi Kitamura

Zitieren

APA

Horie, S., Shikata, F., Oka, N., Okamura, T., Matsunaga, Y., Matsui, K., Hataoka, T., Kitamura, T., Fukuzumi, M., Kondo, R., Hirata, Y., & Miyaji, K. (2025). Liver fibrosis marker is a potential predictor of the development of Fontan-associated liver diseases. European Journal of Cardio-Thoracic Surgery, 67(4). https://doi.org/10.1093/ejcts/ezaf100

Vancouver

Horie S, Shikata F, Oka N, Okamura T, Matsunaga Y, Matsui K, et al. Liver fibrosis marker is a potential predictor of the development of Fontan-associated liver diseases. European Journal of Cardio-Thoracic Surgery. 2025;67(4). doi:10.1093/ejcts/ezaf100

BibTeX
@article{Horie2025,
  author = {Horie, Sakura and Shikata, Fumiaki and Oka, Norihiko and Okamura, Toru and Matsunaga, Yoshikiyo and Matsui, Kenta and Hataoka, Tsutomu and Kitamura, Tadashi and Fukuzumi, Masaomi and Kondo, Ryoichi and Hirata, Yoichiro and Miyaji, Kagami},
  title = {Liver fibrosis marker is a potential predictor of the development of Fontan-associated liver diseases},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  volume = {67},
  number = {4},
  doi = {10.1093/ejcts/ezaf100}
}
Kostenlos starten →